Detalles de la búsqueda
1.
Comparative phase I randomized open-label pilot clinical trial of Gynophilus® (Lcr regenerans®) immediate release capsules versus slow release muco-adhesive tablets.
Eur J Clin Microbiol Infect Dis
; 37(10): 1869-1880, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032443
2.
Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®.
Appl Microbiol Biotechnol
; 99(1): 399-411, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25280746
3.
In vivo investigation of Lcr35® anti-candidiasis properties in Caenorhabditis elegans reveals the involvement of highly conserved immune pathways.
Front Microbiol
; 13: 1062113, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620055
4.
Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model.
Cartilage
; 13(2_suppl): 1204S-1213S, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982336
5.
Caenorhabditis elegans, a Host to Investigate the Probiotic Properties of Beneficial Microorganisms.
Front Nutr
; 7: 135, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425969
6.
Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial: a mixed-methods approach.
BMJ Open
; 10(5): e031819, 2020 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434932
7.
Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Sci Rep
; 10(1): 17074, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33051479
8.
Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing.
Sci Rep
; 10(1): 3884, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32127550
9.
Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35® in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights.
Microorganisms
; 8(1)2019 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31878039
10.
Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
PLoS One
; 14(11): e0216184, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31693670
11.
Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
Eur J Pharm Biopharm
; 88(3): 787-94, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25128853
12.
Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations.
PLoS One
; 8(11): e79041, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24244412
13.
Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
J Biotechnol
; 160(3-4): 236-41, 2012 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-22542933
Resultados
1 -
13
de 13
1
Próxima >
>>